Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or District of Columbia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to District of Columbia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. District of Columbia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Rebin Kader (NPI 1174938807)

Field	Value
Entity Type	Individual
Organization	Rebin Kader
Address	2021 K Street Nw
City	Washington
State	DC
ZIP	20006
Taxonomy	Allergy Physician
NPI Enumerated	June 20, 2014

Payer Source	Total Paid
Medicare	$492K
Medicaid	$0

Key Findings

This provider’s Medicare footprint is the sole payer presence in the data set: total Medicare revenue is $492K and there is no Medicaid billing on file, so the observed business is effectively single-payer Medicare. That payer concentration means almost all measurable billing activity and revenue exposure for this provider comes through Medicare claims.

Revenue is heavily concentrated in a very small set of biologic and related services: the precomputed top-3 Medicare codes account for 96.4% of total Medicare revenue, with J3111 contributing $366.2K (74.3%), J0897 contributing $99.4K (20.2%), and 99204 contributing $9.3K (1.9%). This degree of concentration signals that a narrow set of therapies drives the vast majority of billed dollars.

The code mix indicates a specialty practice oriented to in-office administration of bone-targeted biologics: J3111 (romosozumab) and J0897 (denosumab) together represent roughly 94.5% of Medicare revenue, which is consistent with a clinical focus on osteoporosis or similar bone-health treatment requiring on-site injections. Supporting procedure codes (96372, 96365, 96374) and the presence of chemotherapy/infusion code 96413 suggest the practice performs frequent injections/infusions as a core operational activity rather than primarily office-based evaluation-and-management.

J3111 ranks #80 of 970 nationally and is reported at the 92th percentile with a plain-English label of "typical, unremarkable volume for this code," indicating the provider occupies a relatively high national position for romosozumab administration while that activity remains within expected peer norms. J0897 ranks #2550 of 10057 (74th percentile) and is also characterized as "typical, unremarkable volume for this code," which positions the provider as a moderate national participant for denosumab.

Procedural injection volume shows a distinct outlier signal: 96372 has 473 claims, $5.2K revenue (1.1% of total Medicare revenue) and ranks #1811 of 58224 at the 97th percentile, described as "notably above typical national volume for this code." This suggests above-average throughput of therapeutic/subcutaneous injections relative to peers, even though that code is a small share of revenue.

Evaluation-and-management codes contribute only a small share of revenue relative to biologics: 99204 produced $9.3K (1.9% of Medicare revenue) and 99214 produced $5.2K (1.1% of Medicare revenue), both labeled as "typical, unremarkable volume for this code." This pattern indicates the practice’s revenue model is dominated by drug administration rather than office visit billing.

From a competitive/operational perspective, the provider is not broadly diversified across payers or service lines: dominant revenue dependence on J3111 and J0897 makes the practice sensitive to formulary, reimbursement, or utilization-management changes affecting these biologics. Payers or network analysts should treat utilization and prior-authorization patterns for these two codes as primary levers that could materially change billed Medicare revenue.

The provider’s NPI has been enumerated since 2014-06-20 (~12 years ago), indicating more than a decade of enrollment; combined with the concentrated drug-administration profile, this tenure suggests an established specialty practice with a stable focus on in-office biologic therapy delivery.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

9 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J3111	Injection, romosozumab-aqqg, 1 mg	45,780	$10	$366.2K
J0897	Injection, denosumab, 1 mg	5,520	$20	$99.4K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	80	$120	$9.3K
96372	A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician…	470	$10	$5.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	50	$100	$5.2K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	40	$90	$3.3K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	60	$50	$2.9K
J3489	Injection, zoledronic acid, 1 mg	130	$10	$780
96374	The provider administers a single medication or other substance rapidly into a vein to treat, prevent, or diagnose a condition.	20	$30	$570

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 9 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. District of Columbia Distribution

Rebin Kader — 2 of 9 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — District of Columbia

Full comparison — all codes billed, vs. state median

9 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J3111	1	10	24,360	$10	$204.1K
J0897	6	20	4,680	$20	$91.2K
99214	939	1,400	90	$100	$15.3K
96413	15	20	60	$120	$11.4K
99204	139	670	30	$130	$6.4K
96365	2	20	30	$60	$1.9K
96374	2	10	30	$30	$970
96372	1	50	40	$10	$800
J3489	3	10	90	$10	$630

Related Providers

Other providers that share a Tax Identification Number (TIN) with Rebin Kader, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Uch-mhs	CO	General Acute Care Hospital	$0	$69M
Poudre Valley Medical Group, LLC	CO	General Practice Physician	$0	$14.9M
Poudre Valley Medical Group, LLC	CO	General Practice Physician	$0	$8M
Fort Collins Radiologic Associates PC	CO	Diagnostic Radiology Physician	$0	$6.4M
Poudre Valley Medical Group, LLC	CO	Urgent Care Clinic/Center	$0	$6M
Inder Singh	CA	Interventional Cardiology Physician	$4.7M	$0
Jodie Gallegos	CO	Family Nurse Practitioner	$2.8M	$0
Cedar Valley Pathologists PC	IA	Clinical Pathology/Laboratory Medicine Physician	$0	$1.8M
James Levine	CO	Rheumatology Physician	$1.7M	$0
John Watkins	ND	Radiation Oncology Physician	$1M	$0

Nearby Providers

Other providers in the same ZIP code as Rebin Kader, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Capitol View Home Healthcare Agency	DC	Respite Care	$0	$26.2M
Amazing Grace Supports Inc	DC	In Home Supportive Care Agency	$0	$20.2M
Mba Non Profit Solutions, LLC	DC	Developmentally Disabled Services Day Training Agency	$0	$3.4M
Premier Support Services Inc	DC	Case Management Agency	$0	$2.9M
Hamid Saranjam	DC	Orthodontics and Dentofacial Orthopedics Dentistry	$0	$1.8M
District Endodontics PLLC	DC	Endodontics	$0	$1.8M
Kerman Dental LLC	DC	General Practice Dentistry	$0	$1.4M
Lifetree Health, Inc	DC	Primary Care Clinic/Center	$0	$1.2M
Kaveh Zand	DC	Endodontics	$0	$1M
Limitless Possibilities, LLC.	DC	Mental Health Counselor	$0	$741.8K

Rebin Kader — Billing Profile & Reimbursement Data

Sign up for Rebin Kader — Billing Profile & Reimbursement Data policy alerts

Rebin Kader — Billing Profile & Reimbursement Data

Sign up for Rebin Kader — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References